The multiplex fluorescence results of tumour samples from HER2 + IBC patients also confirmed that PTN was mainly expressed in tumour cells (Extended Data Fig. S10a), while NCL had variable expression levels in various cell types, among which B cells and tumour cells were the main high-expression cell types of NCL (Extended Data Fig. S10b). This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.